Onyx Pharmaceuticals, Inc.
Uradni registerski podatki
0sledilcev
2013ustanovljeno
O Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. was a pharmaceutical company headquartered in South San Francisco, California that developed and marketed cancer treatment medications. It was founded and incorporated with the California Secretary of State in February 1992 by venture capitalist Kevin J. Kinsella and Frank McCormick, Ph.D., FRS, D.Sc. (Hon.), a renowned British-American biochemist. McCormick served as the chief scientific officer until 1996, while Kinsella chaired the company's board of directors. On March 26, 1996, Onyx withdrew its corporate registration with the California Secretary of State and reincorporated in the state of Delaware in advance of successfully taking the company public on the NASDAQ exchange using National Market symbol ONXX on May 9, 1996. In 2009, the company acquired private biotechnology company Proteolix for US$276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" in an industry survey conducted by the ISI Group. Onyx president and CEO N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, by the end of August 2013, Amgen announced that it was acquiring Onyx in an agreed US$10.4 billion deal.
Source: Wikipedia
SedežCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Ustanovljeno2013
StatusAktivno
Patenti60 patentov
METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOREP4558143A4 · 2026
Methods of treating multiple myelomaUS12636340B2 · 2026
Prijavite se, da si ogledate vseh 60 patentov
Prebrskajte celoten portfelj patentov, s številkami objav, datumi in patentnimi družinami.
Prijavite se Ustvarite račun s svojim e-poštnim naslovomBrezplačno je
Z nadaljevanjem se strinjate z uporabniško pogodbo, pravilnikom o zasebnosti in pravilnikom o piškotkih družbe Heelky.
Ocene
Mnenj še ni. Ste sodelovali s Onyx Pharmaceuticals, Inc.? Bodite prvi, ki deli izkušnjo.
Pravne informacije
| Pravno ime | Onyx Pharmaceuticals, Inc. |
|---|---|
| LEI | 549300K47GO90N8J4853Ogled na GLEIF ↗ |
| Registrirani naslov | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Status | Aktivno |
Viri: GLEIF · posodobljeno 16. oktober 2026
Stik in povezave
Lokacija
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Je to vaše podjetje?
To stran brezplačno prevzemite, da dodate logotip, izdelke, fotografije in zaposlitve ter odgovorite na mnenja.
Prevzemite to stranPridružite se Heelky, da se povežete, zaposlite in rastete
Ustvarite brezplačen račun, da ljudem pišete, se prijavljate na zaposlitve in objavljate misije.
Pridruži se zdaj — brezplačno je